Biogen, Inc. (BIIB)
191.77
-3.36
(-1.72%)
USD |
NASDAQ |
Feb 25, 10:51
Biogen Price : 191.77 for Feb. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1036.67 |
| Merck & Co., Inc. | 123.00 |
| AbbVie, Inc. | 230.74 |
| Pfizer Inc. | 26.75 |
| Stoke Therapeutics, Inc. | 35.80 |
Price Related Metrics
| PE Ratio | 21.78 |
| PS Ratio | 2.953 |
| Price to Book Value | 1.542 |
| Price to Free Cash Flow | 14.29 |
| Earnings Yield | 4.59% |
| Market Cap | 28.14B |
| Operating PE Ratio | 11.63 |
| Normalized PE Ratio | 16.45 |